1-4 of 4
Benjamin Eckert
Close
Sort by
Journal Articles

MRD Assessment Using Next-Generation Sequencing (clonoSEQ® Assay) Among Fee-for-Service Medicare Beneficiaries with Newly Diagnosed Multiple Myeloma Who Received Transplant

Miao Jiang, Peter Kardel, Irene Varghese, Anthony Hewitt, Heidi Simmons, Benjamin Eckert
Journal: Blood
Blood (2022) 140 (Supplement 1): 13102–13104.
https://doi.org/10.1182/blood-2022-170116
Published: 2022
Journal Articles

Longitudinal MRD Assessment in Real-World Multiple Myeloma Patients Using Next-Generation Sequencing (clonoSEQ® Assay)

Miao Jiang, Lik Wee Lee, Benjamin Eckert, Audrey Demaree, Tony Hewitt
Journal: Blood
Blood (2021) 138 (Supplement 1): 3783.
https://doi.org/10.1182/blood-2021-153774
Published: 2021
Journal Articles

Cost-Effectiveness of Implementing Clonoseq NGS-MRD Testing Using the Emory MRD Decision Protocol in Multiple Myeloma

Josh J Carlson, MPH, PhD, Marita Zimmermann, MPH, PhD, Audrey Demaree, PharmD, Tony Hewitt, Benjamin Eckert, Ajay Nooka, MDMPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-143234
Published: 2020
Journal Articles

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Nicole M. Engel-Nitz, Ph.D., Benjamin Eckert, MS, Rui Song, PhD, Erin M. Hulbert, MS, Jeffrey McPheeters, April Teitelbaum, MD, MS, FACP
Journal: Blood
Blood (2012) 120 (21): 4700.
https://doi.org/10.1182/blood.V120.21.4700.4700
Published: 2012